Нурофен Экспресс Леди

Quick links

Choose a section

Quick links to important sections

Advertisements

Нурофен Экспресс Леди

Selected form

Advertisements

Overview of Нурофен Экспресс Леди

Quick Facts

Property Description
Active Ingredient Ibuprofen Lysinate
Form Oral (Film-coated tablets/Soft capsules)
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
General Use Symptomatic relief from pain, inflammation, and fever
Origin Synthetic chemical compound

What Type of Medicine is Нурофен Экспресс Леди?

Нурофен Экспресс Леди is a branded monocomponent medicinal product classified pharmacologically as a Nonsteroidal Anti-inflammatory Drug (NSAID). Its core function is to provide systemic symptomatic relief by reducing discomfort associated with general pain and fever. The medication belongs chemically to the Propionic acid derivatives group. Ibuprofen is globally recognized for its analgesic (pain relief), anti-inflammatory, and antipyretic (fever reduction) properties. This confirms that the medicine's fundamental role is to help control the body's generalized pain and fever responses.

Composition and Form: What is Ibuprofen Lysinate?

The active ingredient in this preparation is Ibuprofen, which is specially formulated as the rapidly dissolving salt, Ibuprofen Lysinate. This drug is supplied as an oral dosage form, typically as film-coated tablets or soft gelatin capsules, making it an accessible over-the-counter (OTC) product. Ibuprofen is a synthetic chemical compound, and the use of the Lysinate salt is a strategic chemical modification intended to enhance the drug's solubility and improve the compound's absorption rate compared to standard Ibuprofen acid. This technical feature is the primary differentiator, making the medicine recognized for its speed of action after ingestion.

General Purpose and Core Benefits

The general purpose of the medication is to provide relief by simultaneously controlling three distinct effects: pain, inflammation, and fever. While the drug's mechanism is universally effective, its commercial positioning is focused on providing effective relief for pain syndromes often experienced by women, such as menstrual discomfort. This combination of analgesic, anti-inflammatory, and antipyretic effects offers comprehensive symptomatic utility. The formulation is primarily used to restore general comfort and functional well-being during episodes of temporary discomfort, utilizing its enhanced absorption profile to ensure rapid systemic action.

Regulatory References

  1. Nonsteroidal Anti-inflammatory Drug (NSAID)
  2. analgesic
  3. anti-inflammatory
  4. antipyretic
Advertisements

What side effects are possible with Нурофен Экспресс Леди?

Possible Side Effects and Safety Information

The safety profile of this medicine, which contains Ibuprofen Lysinate, an NSAID, is strictly defined by government regulatory documents. Adverse reactions are formally grouped by the body system affected and classified by frequency of occurrence.

Official Adverse Reactions and Frequencies

Adverse reactions are formally classified to communicate likelihood:

Classification Examples of Documented Effects
Common Dyspepsia, nausea, vomiting, abdominal pain, headache, dizziness.
Uncommon Hypersensitivity reactions (e.g., skin rashes, pruritus), gastrointestinal ulceration.
Rare Visual disturbances, aseptic meningitis, and certain blood-formation disturbances.
Very Rare Severe skin reactions (e.g., Stevens-Johnson Syndrome), anaphylactic shock.

Regulatory Safety Patterns and Constraints

Official labeling emphasizes high-level risks and use limitations:

  • Serious Adverse Reactions: Regulatory authorities document the risk of serious gastrointestinal events (bleeding, ulceration, perforation) and serious cardiovascular thrombotic events (myocardial infarction and stroke), which can occur without warning.
  • System-Organ Classes: The most significant documented concerns involve the Gastrointestinal, Cardiovascular, Renal, and Immune Systems.
  • Duration and Dose: The risk of serious adverse events is stated to increase with duration of use and higher doses.
  • Population-Specific Notes: Older adults are identified as having a higher risk of serious GI adverse effects. The medication is contraindicated during the last trimester of pregnancy and in patients with pre-existing severe heart, renal, or hepatic failure.

Official Safety Summary

This information structures the understanding of the medicine's risk profile, focusing on major organ systems and known risk factors. The product is generally labeled for short-term, symptomatic use only, and is subject to strict contraindications based on the potential for severe, documented adverse reactions.

Advertisements

Overdose and Emergency Response

Any suspected overdose of Ibuprofen Lysinate requires immediate medical attention; individuals should contact emergency services or a Poison Control Center right away, as mandated by regulatory authorities. The official labeling documents that an overdose may initially present with gastrointestinal disturbances, including nausea, vomiting, abdominal pain, and heartburn. Central nervous system (CNS) effects are also noted, such as drowsiness, lethargy, dizziness, severe headache, and tinnitus.

However, significant overdose carries the risk of life-threatening manifestations that necessitate hospital monitoring. These serious outcomes, explicitly documented in prescribing information, include acute renal failure, gastrointestinal hemorrhage or perforation, hypotension, and severe neurological events like convulsions or coma. There is an increased susceptibility to severe toxicity in patients with pre-existing conditions, such as renal or cardiac impairment.

The officially defined management procedure is strictly symptomatic and supportive treatment, as regulatory documents state that no specific antidote is known for Ibuprofen overdose. Supportive interventions may include monitoring vital signs, stabilizing blood pressure with intravenous fluids, and considering activated charcoal for gastric decontamination.

Advertisements

Therapeutic Uses of Нурофен Экспресс Леди

What Нурофен Экспресс Леди Treats: Main Uses and Benefits

The medication, containing the active ingredient Ibuprofen Lysinate, is commonly used to provide supportive relief across domains where additional symptomatic support is needed. The medication is considered relevant for easing symptoms related to physical discomfort and systemic imbalance across three core symptomatic areas: pain, inflammation, and fever.

It is generally used for managing symptoms associated with acute pain syndromes, including tension headaches, toothaches, minor muscular aches, and is considered relevant for managing the recurrent discomfort of primary dysmenorrhea (menstrual pain). The product is also applied in addressing elevated body temperature and generalized aches related to systemic illness like the common cold or flu.

“A main benefit is offering symptomatic relief that helps patients cope more steadily with difficult episodes.”

This use in acute or episodic symptom patterns means the medication plays a role in managing symptoms that interfere with daily functioning, and provides support that helps ease the overall symptom burden when discomfort becomes more noticeable.

Quick Fact: Relief for Pain and Fever
Target Symptoms: Acute pain, fever, localized inflammation, menstrual cramps (dysmenorrhea).
Core Benefit: Supports comfort and assists with maintaining functional stability in situations where symptoms interfere with daily functioning.
Typical Context: Seasonal illness, minor injuries, post-dental procedure discomfort, and cyclical pain.

Regulatory References

  1. NIH MedlinePlus Drug Information overview on Ibuprofen
Advertisements

Eligibility and Restrictions for Use

Population Eligibility: Official Regulatory Information

The eligibility for using Нурофен Экспресс Леди (Ibuprofen Lysinate) is strictly governed by regulatory classifications based on age, pre-existing conditions, and physiological state. The medication is generally allowed for adults and adolescents aged 12 years and above who weigh 40 kg or more. Older adults may use it but require careful monitoring.

Absolute Contraindications

Use is strictly contraindicated in patients with a known history of hypersensitivity to Ibuprofen or other NSAIDs (including aspirin), a history of recurrent peptic ulcer/haemorrhage, or severe heart, kidney, or liver failure. It is also contraindicated for any use during the last trimester of pregnancy and in patients experiencing severe dehydration.

Restrictions and Limitations

Use is not recommended during the first six months of pregnancy unless considered necessary by a physician. Caution is required for patients with pre-existing conditions like mild to moderate organ impairment, uncontrolled hypertension, specific cardiovascular diseases, or a history of inflammatory bowel diseases (Crohn's Disease, Ulcerative Colitis).

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction patterns for Ibuprofen Lysinate (the active ingredient), based strictly on the classification and requirements found in government regulatory prescribing information.


Interactions Prohibited by Label

Co-administration of Ibuprofen Lysinate with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including selective COX-2 inhibitors, is contraindicated due to a significantly enhanced risk of gastrointestinal adverse events. Similarly, co-use with high-dose Aspirin (Acetylsalicylic Acid) is formally prohibited.

Pharmacodynamic and Exposure-Altering Interactions

The official interaction profile identifies substances that reinforce adverse risks. Co-administration with Anticoagulants (like Warfarin), Antiplatelet agents, and SSRIs increases the risk of serious bleeding. Ibuprofen also interacts with agents involved in blood pressure management, potentially reducing the efficacy of Diuretics and Antihypertensives while increasing the risk of impaired kidney function.

In terms of drug exposure, Ibuprofen reduces the renal clearance of substances such as Lithium and Methotrexate. This leads to an increase in the plasma concentrations of these co-administered agents. Additionally, co-use with potent CYP2C9 Inhibitors (e.g., Fluconazole) may officially increase the systemic exposure of Ibuprofen itself.

Timing and Population Constraints

To avoid interference with the antiplatelet effect of low-dose Aspirin, official documents advise separating the doses. The severity of interactions is generally noted to be increased in the elderly population and in patients with pre-existing renal or hepatic impairment. The regulatory profile also includes a constraint regarding Alcohol consumption, which increases the risk of GI bleeding.

Advertisements

Mechanism of Action

How Нурофен Экспресс Леди Works

Targeted Enzyme Inhibition in Signaling Pathways

The drug's core action is the non-selective, reversible competitive inhibition of the Cyclooxygenase (COX) enzymes (COX-1 and COX-2). This mechanism acts early in the molecular cascade by blocking the enzymes from processing arachidonic acid, a necessary step for creating chemical mediators. This targeted interference is the foundational step that influences the resulting physiological effects.

Modulation of Prostaglandin Synthesis

By inhibiting COX activity, the mechanism directly leads to a reduced synthesis in the body’s output of prostaglandins (PGs), particularly Prostaglandin E2 (PGE2). As PGs are key signaling molecules that sensitize nerve endings and regulate temperature, their lowered concentration mediates the adjustment of affected physiological pathways.

Regulating Central and Peripheral Responses

The reduced PGE2 concentration leads to a combined physiological outcome. Peripherally, it results in the reduced chemical sensitization of nociceptors and modulation of localized vascular changes. Centrally, the mechanism influences the adjustment of the hypothalamic temperature set point, collectively leading to altered activity across these regulatory systems.

Advertisements

Dosage and Administration Information

The administration of this medicine is defined by strict adherence to guidelines regarding route, dosage, frequency, and duration. As an oral formulation, the medication, typically supplied as a film-coated tablet or soft capsule, is intended to be swallowed whole with a glass of water, and should not be chewed or crushed. The official instructions note that individuals with a history of gastric sensitivity are advised to ingest the dose with food, although this may slightly delay the time required for systemic absorption.

The standard labeled regimen for adults and adolescents weighing 40 kg or more starts with a single dose of 200 mg to 400 mg of Ibuprofen equivalent. Subsequent doses, if required, must be separated by a minimum time interval of 4 to 6 hours. The frequency is limited to a maximum of three separate doses in any 24-hour period. A crucial procedural constraint is that the total intake must not exceed 1200 mg Ibuprofen equivalent per day.

Use Patterns and Duration

The medicine is strictly intended for short-term use only and the duration of administration is limited. Official labeling specifies that the duration of use must not exceed 3 days for managing fever or 4 to 5 days for addressing pain. This short-term use principle extends to all populations, including older adults who generally do not require a special initial dose adjustment; the core directive remains to employ the lowest effective dose for the shortest duration necessary.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Нурофен Экспресс Леди

The research for this medicine, which contains Ibuprofen Lysinate, is based on two main lines of inquiry: the established evidence for the core active ingredient (Ibuprofen) and specific studies examining the absorption characteristics of the Lysinate salt formulation. This overview describes the structure of available studies without offering clinical advice or making claims about individual outcomes.


Evidence for Acute Pain Relief (General Analgesia Model)

Research exploring the specific characteristics of the Ibuprofen Lysinate formulation was conducted in models of acute, temporary pain, such as post-operative dental discomfort in adult populations. These short-term, randomized controlled trials (RCTs) typically research examined self-reported pain intensity using standard scales. Pharmacokinetic studies described a pattern of absorption for the Lysinate salt when compared to the standard Ibuprofen acid.

Some comparative trials described patterns where the overall observed symptom patterns of the two formulations were similar in the context of symptom change over a defined time interval. Furthermore, findings were mixed regarding whether the Lysinate salt demonstrated a significantly faster onset of measured changes in physical discomfort compared to the standard acid formulation when assessed by patient-reported outcomes.


Evidence for Primary Dysmenorrhea (Menstrual Pain)

The active ingredient in this medication was evaluated in studies involving periods of heightened symptoms, specifically outcomes related to physical discomfort during primary dysmenorrhea (menstrual pain). Research relevant in trials assessing short-term or episodic symptom patterns involves randomized, controlled trials that explored how symptoms evolved in menstruating individuals dealing with this common condition.

The findings indicate patterns where the active ingredient was observed in studies related to recorded changes in physical discomfort during phases of heightened symptom activity. Research highlights changes measured during these short-term study periods, including recorded differences in self-reported pain intensity.


Current Evidence Gaps and Research Uncertainty

Data are still emerging for certain subgroups, and evidence is limited for use in certain patient groups, including older adults or individuals with certain mild comorbidities. Information regarding prolonged periods of use is not fully established, and there is limited information for long-term outcomes that would characterize use over extended periods. Ultimately, study results reflect the specific conditions under which they were conducted; this means research provides insight into short-term changes but does not determine whether an individual will respond similarly outside the trial settings.

Key Studies & References

  1. Ibuprofen Monograph: MedlinePlus Drug Information
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Нурофен Экспресс Леди (FAQ)


Q: What is the difference between Nurofen Express Lady and regular Nurofen?

Official documents indicate that Nurofen Express Lady contains ibuprofen in the form of the lysinate salt. This salt form has been studied for its enhanced absorption characteristics compared to standard ibuprofen acid. However, the core active substance and its general pharmacological action remain the same.


Q: Why is it called 'Express Lady,' is it only for women?

According to the official product information, the medicine is indicated for treating pain, including menstrual pain (primary dysmenorrhea), as well as other types of pain and fever. Regulatory instructions do not typically specify restrictions based on sex; however, specific constraints apply regarding pregnancy and lactation.


Q: Does Nurofen Express Lady help with severe menstrual pain?

The drug is officially indicated for the short-term symptomatic treatment of pain, including menstrual pain (dysmenorrhea). Official documents do not typically distinguish between moderate and severe pain for initial indication. If symptoms are not relieved, consultation with a healthcare professional is the appropriate next step as described in general patient safety guidance.


Q: Can I take Nurofen Express Lady on an empty stomach?

Official instructions indicate that individuals with a history of gastric sensitivity are advised to ingest the dose with food. While taking it with food may slightly delay the onset of the effect, this information is specifically directed at users with stomach sensitivities.


Q: What side effects are most commonly reported by users?

The side effects officially classified as 'Common' in regulatory documents include dyspepsia (indigestion), nausea, vomiting, abdominal pain, headache, and dizziness.


Q: Can Nurofen Express Lady cause stomach problems?

Official product information warns about the risk of serious gastrointestinal events, such as bleeding, ulceration, or perforation. The likelihood of these effects is stated to increase with higher doses and longer duration of use.


Q: Does alcohol consumption affect the action or safety of Nurofen Express Lady?

Official documents explicitly state that consuming alcohol while taking the medication increases the risk of gastrointestinal bleeding.


Q: Can I take Nurofen Express Lady with other painkillers at the same time?

Regulatory documents prohibit co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and high-dose Acetylsalicylic Acid (Aspirin). Information regarding the safe co-use with non-NSAID painkillers requires review by a healthcare professional.


Q: Are there age restrictions for taking this drug?

The medicine is indicated for use in adults and adolescents weighing 40 kg or more, which generally corresponds to individuals aged 12 years and older. The medication is intended for use in adults and adolescents who meet these weight criteria.


Q: Can Nurofen Express Lady be used while breastfeeding?

Official information indicates that ibuprofen is transferred into breast milk in very low concentrations. Based on official information, it has been observed that there is generally no need to interrupt breastfeeding during short-term use at the recommended dosages.


Q: Is Nurofen Express Lady allowed during pregnancy?

The medication is contraindicated (prohibited) during the third trimester of pregnancy. During the first and second trimesters, its use is conditioned on it being strictly necessary and limited to the shortest possible duration at the lowest effective dose.


Q: Can the drug cause drowsiness or affect driving ability?

While the product information lists common effects like headache and dizziness, individuals experiencing these, or less common effects like drowsiness or visual disturbances, official information indicates that these individuals should avoid driving or operating machinery.


Q: Does Nurofen Express Lady affect blood pressure?

Regulatory information indicates the drug may reduce the effectiveness of diuretics and antihypertensive agents (blood pressure medications). Additionally, caution is advised for patients with existing blood pressure issues or heart failure, as NSAIDs can cause fluid retention and swelling (edema).


Q: Does it help with toothache?

Yes, the product is officially indicated for the short-term symptomatic treatment of mild and moderate pain, which includes dental pain (toothache).


Q: Are there special instructions for storing the drug?

Official instructions specify that the medicine should be stored out of the sight and reach of children and maintained at a specific temperature (usually not above 25°C), ideally in its original packaging to protect it from light and moisture.


Q: Do I need to change the dosage if I start to feel better?

Official guidelines recommend using the minimal effective dose for the shortest duration necessary to relieve symptoms. This is consistent with the principle of discontinuing use once symptoms are fully relieved.


Q: Does it affect a woman's hormone levels?

Official safety information notes that drugs which inhibit prostaglandin synthesis (NSAIDs) may cause reversible impairment of female fertility by affecting ovulation. It does not provide information on other hormonal impacts.


Q: Can I use it for fever or elevated temperature?

Yes, the medication is formally indicated for the short-term symptomatic treatment of fever (elevated temperature).


Q: Does Nurofen Express Lady help with migraines?

Some regulatory documents specify that products containing the active ingredient ibuprofen lysinate are indicated for the relief of headaches and pain associated with migraine.


Q: What does the composition include besides the active ingredient?

Official regulatory documents include a complete list of excipients (inactive ingredients) used in the product. These typically include substances like fillers, colorants, coating agents, and stabilizers, which vary by exact dosage form.


Q: Can Nurofen Express Lady affect the menstrual cycle?

While direct effects on cycle timing are not described, official information states that NSAIDs may cause reversible impairment of female fertility due to their potential impact on the process of ovulation.


Q: What interactions with food products are possible?

In addition to the risk associated with alcohol, regulatory documents caution that some herbal extracts, such as Ginkgo biloba, may potentially increase the risk of bleeding when taken alongside NSAIDs.


Q: Can it help with back pain?

The product is indicated for the short-term symptomatic relief of mild and moderate pain. This category often includes muscular and joint pain, which may encompass back pain. The indication is for acute, mild to moderate pain.


Q: Are there any specific age restrictions (e.g., for adolescents)?

The drug is authorized for use in adolescents who weigh 40 kg or more, which generally means individuals 12 years of age and older. For children who do not meet these criteria, use is not authorized.


Q: Why do some people say the 'Lady' version works faster?

Official studies for the ibuprofen lysinate form have focused on demonstrating its enhanced rate of absorption compared to standard ibuprofen. This pharmacokinetic difference is the scientific basis for the 'Express' labeling and likely contributes to the user perception of faster action.


Q: Do I need to continue taking it if the pain is gone?

Instructions recommend that the medication be used for short-term treatment only, employing the lowest effective dose for the shortest period. This aligns with the principle of discontinuing use once symptoms have been fully relieved.


Q: Can it cause water retention in the body?

Official information warns that NSAIDs, as a class, may cause fluid retention and swelling (edema). This specific warning is considered particularly important for patients with existing heart or kidney problems.


Q: Are there studies on safety for long-term use?

Regulatory documents stress that the product is intended for short-term use only. The risk of serious side effects increases with increasing dose and duration of treatment, meaning that official information on long-term safety is explicitly limited.


Q: Are there warnings for people with asthma?

The medicine is contraindicated (not allowed) for patients who have previously experienced hypersensitivity reactions, such as asthma, urticaria, or rhinitis, after taking aspirin or other NSAIDs.


Q: Does the dosage form (capsules) affect the speed of action?

While the dosage form can influence dissolution, official documents emphasize that the chemical salt form (lysine) is the primary factor enabling the enhanced absorption characteristic. The formulation supports this delivery method.


Q: Can I take Nurofen Express Lady if I am taking antidepressants?

Official regulatory documents describe a known interaction with SSRIs (Selective Serotonin Reuptake Inhibitors), a common class of antidepressants. Co-administration increases the risk of gastrointestinal bleeding.


Q: Do I need to drink a lot of water with the tablet?

The official administration instructions specify that the tablet should be swallowed whole with a glass of water.


Q: How do I know when to stop taking it and see a doctor?

Official instructions indicate that if signs of a gastrointestinal bleed (e.g., blood in stool) or serious skin reactions (e.g., rash, blistering) occur, the medicine should be discontinued immediately and professional medical advice sought.


Q: Can men take it?

The dosing and indications detailed in the official documents apply to adults and adolescents weighing 40 kg or more. There are no restrictions based on sex, aside from those specific to pregnancy and lactation.

Advertisements

How should Нурофен Экспресс Леди be stored and disposed of?

How to Store and Dispose of Нурофен Экспресс Леди?

The official storage and handling instructions for this medicine are established to maintain its quality and stability.


Storage Requirements

The product must be stored at a temperature not exceeding 25°C and should remain in its original container to ensure proper protection from light and moisture. This medication must always be stored out of the sight and reach of children, as required by official government labeling for all medicines.


Disposal Instructions

To discard expired or unused medicine, follow the instructions provided by the official labeling. Disposal must be carried out in accordance with local requirements. The medicine should not be disposed of in general household waste or flushed down wastewater, as this protects the environment and prevents potential contamination. Consult a pharmacist or local waste management service for proper take-back options.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Нурофен Экспресс Леди found in:

A-Z Index: